IGFs can contribute to cancer development through several mechanisms. Elevated levels of IGF-1 and IGF-2 have been linked to increased cell proliferation and reduced apoptosis (programmed cell death), which can lead to tumor growth. Additionally, IGF signaling can enhance angiogenesis (the formation of new blood vessels) and metastasis (the spread of cancer cells to other parts of the body).
